|
Nutra Pharma Corporation is
a biotechnology company specializing in the acquisition,
licensing and commercialization of pharmaceutical
products and technologies for the management of
neurological disorders, cancer, autoimmune and
infectious diseases.
| |
|
| Nutra
Pharma, through its wholly-owned drug discovery
subsidiary, ReceptoPharm, is developing
proprietary therapeutic protein products
primarily for the prevention and treatment
of viral and neurological diseases in humans,
including Multiple Sclerosis (MS), Adrenomyeloneuropathy
(AMN), and Human Immunodeficiency Virus
(HIV). The emphasis of ReceptoPharm's approach
to drug discovery and the development of
new therapeutic agents is based upon specialized
receptor-binding proteins found in nature,
especially those found in snake venom from
the cobra. |
|
|
| |
|
| Designer Diagnostics is the wholly-owned
medical devices subsidiary of Nutra Pharma.
The Company was established in 2005 for the
marketing and sales of rapid diagnostics test
kits for infectious diseases, including Nontuberculous
Mycobacteria (NTM) and Tuberculosis (TB). |
|
| Learn
More |
|
|
| |
|
|
|
| |
|
| Click
Here to learn about Nutra Pharma’s focus on
financial sustainability. |
|
|
|
|
| |
|
